Federico Grossi - 12 Jan 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: CHIEF MEDICAL OFFICER
Signature: /s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Issuer symbol: APLS
Transactions as of: 12 Jan 2022
Net transactions value: +$20,230
Form type: 4
Filing time: 14 Jan 2022, 15:57:52 UTC
Previous filing: 04 Jan 2022
Next filing: 19 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Options Exercise	$13,765	+3,661	+5.2%	$3.76^*	74,015	12 Jan 2022	Direct
transaction	APLS	Common Stock	Options Exercise	$6,465	+1,500	+2%	$4.31^*	75,515	12 Jan 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Options Exercise	$0	-3,661	-100%	$0.000000^*	0	12 Jan 2022	Common Stock	3,661	$3.76	Direct	F1
transaction	APLS	Stock Option (Right to Buy)	Options Exercise	$0	-1,500	-2.1%	$0.000000	68,823	12 Jan 2022	Common Stock	1,500	$4.31	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This stock option was granted on 02/08/2016 and is fully vested.
F2	This stock option was granted on 08/21/2017 and is fully vested.